2 ML bupivacaine hydrochloride 7.5 MG/ML Injection — RxCUI 1724784
RxNorm drug concept · Semantic clinical drug
RxCUI 1724784
Semantic clinical drug · SCD
● Current RxNorm concept 5 FDA products
7 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1724784
Official name2 ML bupivacaine hydrochloride 7.5 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbupivacaine HCl 15 MG per 2 ML Injection; BUPivacaine HCl 0.75 % in 2 ML Injection; bupivacaine HCl 0.75 % per 2 ML Injection
FDA products mapped5
Package NDCs mapped7
Reported Medicaid activity (SDUD)941 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Bupivacaine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Bupivacaine is a local anesthetic — it numbs a specific area of your body so you don't feel pain during a procedure. Your doctor or anesthesiologist injects it near the nerves that...
- What exactly is bupivacaine and why is my doctor using it?
- The most common ones are nausea, vomiting, constipation, dizziness, and headache. You might also notice your heart beating a little faster or your blood pressure dropping temporari...
- What side effects should I expect after getting bupivacaine?
🕸️ Concept Web — How 2 ML bupivacaine hydrochloride 7.5 MG/ML Injecti... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
2 ML bupivacaine hydrochloride 7.5 MG/ML Injection
RxCUI 1724784 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Bupivacaine
1815IN -
Bupivacaine hydrochloride
267396PIN
-
Bupivacaine
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Marcaine
1012397BN -
Sensorcaine
202942BN
-
Marcaine
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Bupivacaine Injection
1724783SCDF -
Bupivacaine hydrochloride Injection
2645894SCDFP -
Bupivacaine Injectable Product
1151356SCDG -
Bupivacaine hydrochloride Injectable Product
2661322SCDGP -
Bupivacaine Injection [Marcaine]
1724791SBDF -
Bupivacaine Injection [Sensorcaine]
1724806SBDF -
Bupivacaine hydrochloride Injection [Marcaine]
2657348SBDFP -
Bupivacaine hydrochloride Injection [Sensorcaine]
2657347SBDFP - +4 more in this family
-
Bupivacaine Injection
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Bupivacaine hydrochloride 7.5 MG/ML
1012390SCDC -
2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine]
1724792SBD -
2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Sensorcaine]
1724807SBD -
Bupivacaine hydrochloride 7.5 MG/ML [Marcaine]
1012408SBDC -
Bupivacaine hydrochloride 7.5 MG/ML [Sensorcaine]
1012458SBDC
-
Bupivacaine hydrochloride 7.5 MG/ML
Showing up to 8 concepts per family — 17 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Bupivacaine hydrochloride 7.5 MG/ML
SCDC · 1012390 -
Bupivacaine Injection
SCDF · 1724783 -
Bupivacaine hydrochloride Injection
SCDFP · 2645894 -
Bupivacaine Injectable Product
SCDG · 1151356 -
Bupivacaine hydrochloride Injectable Product
SCDGP · 2661322
Brand-Name Concepts
-
2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine]
SBD · 1724792 -
2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Sensorcaine]
SBD · 1724807 -
Bupivacaine hydrochloride 7.5 MG/ML [Marcaine]
SBDC · 1012408 -
Bupivacaine hydrochloride 7.5 MG/ML [Sensorcaine]
SBDC · 1012458 -
Bupivacaine Injection [Marcaine]
SBDF · 1724791 -
Bupivacaine Injection [Sensorcaine]
SBDF · 1724806 -
Bupivacaine hydrochloride Injection [Marcaine]
SBDFP · 2657348 -
Bupivacaine hydrochloride Injection [Sensorcaine]
SBDFP · 2657347 -
Marcaine Injectable Product
SBDG · 1180417 -
Sensorcaine Injectable Product
SBDG · 1178964
📦 FDA Products & Package NDCs
5 products · 7 package NDCs
7 package NDCs map to RxCUI 1724784 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00264-9379-88 | 10 AMPULE in 1 CARTON (0264-9379-88) / 2 mL in 1 AMPULE | Bupivacaine Hydrochloride with Dextrose | B. Braun Medical Inc. | 2019-04-02 |
| 00409-1761-10 | 2 CELLO PACK in 1 CARTON (0409-1761-10) / 5 AMPULE in 1 CEL... | Marcaine Spinal | Hospira, Inc. | 2022-08-01 |
| 00409-1761-62 | 800 AMPULE in 1 CASE (0409-1761-62) / 2 mL in 1 AMPULE (040... | Marcaine Spinal | Hospira, Inc. | 2005-05-19 |
| 00409-3613-01 | 10 AMPULE in 1 CARTON (0409-3613-01) / 2 mL in 1 AMPULE (04... | Bupivacaine Spinal | Hospira, Inc. | 2005-01-31 |
| 71351-0022-10 | 10 AMPULE in 1 PACKAGE (71351-022-10) / 2 mL in 1 AMPULE (7... | Bupivacaine Hydrochloride | Brookfield Pharmaceuticals, LLC. | 2023-02-23 |
| 71351-0022-50 | 50 AMPULE in 1 PACKAGE (71351-022-50) / 2 mL in 1 AMPULE (7... | Bupivacaine Hydrochloride | Brookfield Pharmaceuticals, LLC. | 2022-10-31 |
| 73293-0002-02 | 50 AMPULE in 1 PACKAGE (73293-0002-2) / 2 mL in 1 AMPULE (7... | Bupivacaine Hydrochloride | Huons Co., Ltd. | 2019-12-30 |
Observed labelers:
Hospira, Inc. (3) ·
Brookfield Pharmaceuticals, LLC. (2) ·
B. Braun Medical Inc. (1) ·
Huons Co., Ltd. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0665 | Inj, bupivacaine, nos, 0.5mg | 3 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.